Press news

In “Biotech Angel Investing With Yaniv Sneor,” Ben Comer and Yaniv Sneor discuss the background of Mid Atlantic Bio Angels and an overview of the application and investment processes. In addition, Ben and Yaniv review guidelines and advice for biotech companies in search of funding, the importance of exit planning, investing in biotech, and the roles that investors play in the future of life sciences.

YouTube link: https://www.youtube.com/watch?v=fIiH0Dt-D30

Early-stage life sciences companies are increasingly in the spotlight these days, with an uptick in investor interest and M&A activity in the space.

In “The Relationship between Funding and Exit Paths”, MABA founder Yaniv Sneor shares some background about our group and discusses potential exit strategies a young life science company may consider and how an exit strategy will, in most cases, determine the funding

In a recently published article in the International Journal of Gynecology & Obstetrics (IJGO), FEMSelect announced positive results for their EnPlace system. The research was presented during the 2023 International Urogynecology Association 48th Annual Meeting in The Hague, Netherlands. FEMSelect’s EnPlace system offers a new, minimally invasive technique for addressing pelvic organ prolapse without the need for extensive surgery or mesh.

The study titled The EnPlace® sacrospinous ligament fixation—A novel minimally invasive transvaginal procedure for apical pelvic organ prolapse repair: Safety and short-term outcome results, focused on the safety and efficacy of the EnPlace system, a device cleared by the FDA [ Read more… ]

Alzheimer’s Drug Discovery Foundation Joins Astrocyte Pharmaceuticals’ $6M Pre-Series B Financing Round to Expand Development of Cerebroprotectant AST-004

August 18, 2023 12:39 PM Eastern Daylight Time

GROTON, Conn.–(BUSINESS WIRE)–Astrocyte Pharmaceuticals Inc., a clinical-stage drug discovery and development company advancing novel cerebroprotective therapeutics for patients with brain injuries, announced an oversubscribed pre-Series B Bridge financing round of over $6M that was led by Dreavent Capital, and joined by the Alzheimer’s Drug Discovery Foundation, and other investors. The funding will accelerate the clinical development of AST-004, a highly promising therapeutic candidate aimed at treating a broad array of acute brain injuries including stroke and [ Read more… ]

Discover the latest in life science angel fund investing from Yaniv Sneor, founder of Mid Atlantic Bio Angels. Watch his discussion with the California Israel Chamber of Commerce from Feb 28, 2023 for valuable insights.

Link to video